Regional Latent TB Infection (LTBI) Echo Series

Date: August 31- December 14, 2021
Location: Online

The purpose of this training is to increase primary care providers’ knowledge and influence practice change for testing and treatment of TB infection. Topics to be covered will include risk-based screening, available diagnostic tests and interpretation, treatment options, approaches for monitoring and managing patients during treatment, and pediatric considerations for testing and treating LTBI in children. This education series will include a total of 7 webinars and each session will feature a 15- minute didactic session followed by participant-led case presentations and discussion among the network of primary care providers. The series is in collaboration with Brown University.

This webinar series is open to primary care providers and nurse practitioners who are involved in the care of high risk populations to test and treat latent TB infection in primary care.

Upon completion of this conference, participants should be better able to:

  • Explain the rationale for increased focus on identifying and treating TB infection to sustain progress toward TB elimination in the US.
  • Identify priority populations who should be screened for TB infection based on risk.
  • Select appropriate tests for LTBI screening and interpret results within the context of the individual patient.
  • Implement shorter regimens to increase treatment completion among patients with TB infection.
  • Outline the diagnosis and treatment of LTBI in children to prevent increased morbidity and mortality.

In order to meet the learning objectives and receive continuing education credits, participants are required to attend live webinar sessions and complete an evaluation form.

The dates for the live sessions are as shown below.

Date & Time Topic Speaker
Tuesday, August 31 | 12:15 PM-1:15 PM ET LTBI Background Daria Szwarko, DO
Tuesday, September 14 | 12:15 PM-1:15 PM ET Screening and Testing for Latent TB Infection Lynn Sosa, MD
Tuesday, October 5 | 12:15 PM-1:15 PM ET Treatment of LTBI Linda Shipton, MD
Tuesday, October 26 | 12:15 PM-1:15 PM ET Treatment Monitoring and Side Effects Amee Patrawalla, MD
Tuesday, November 9| 12:15 PM-1:15 PM ET Common Challenges and Solutions Henry Fraimow, MD
Tuesday, November 30| 12:15 PM-1:15 PM ET Diagnosis and Treatment of LTBI in Children Silvia Chiang, MD
Tuesday, December 14| 12:15 PM-1:15 PM ET LTBI Advanced Considerations Jane Carter, MD and Ed Zuroweste, MD

These weekly webinar sessions will be hosted via Zoom. Registration is limited to primary care providers who interface with persons at high risk for TB. If you are a primary care provider and would like to register, please contact Shwata Suresh Kumar at

For more information, please click on the link below:

CONTINUING EDUCATION INFORMATION support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All individuals who affect content of continuing education activities are required to disclose to the audience any real or apparent conflict of interest related to the activity. The activity faculty are further required to disclose discussion of off-label/investigational uses in their presentations. These disclosures will be made to the audience at the time of the activity.

This education series is open only to primary care providers and registration is by invitation only.

There is no fee for the webinar series.

Funding for this conference was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

For any additional questions, please contact Shwata Suresh Kumar at



Silvia Chiang, MD
Pediatric Infectious Disease Specialist
Hasbro Children's Hospital

Henry Fraimow, MD
Assistant Professor of Medicine
Cooper Medical School of Rowan University

Amee Patrawalla, MD
Medical Director
Global Tuberculosis Institute

Linda Shipton, MD
Assistant Professor of Medicine
Harvard Medical School

Lynn Sosa, MD
Deputy State Epidemiologist
Connecticut Department of Public Health

Daria Szwarko, DO, MPH
Assistant Professor
Brown University

Ed Zuroweste, MD
TB Medical Consultant
Pennsylvania Department of Health



Jane E. Carter, MD
Associate Professor of Medicine
Brown University

Alyson Conroy
Program Coordinator
Global Health Initiative

Brown University

Anita Khilall, MPH - Activity Director
Program Director, Education & Training
Global Tuberculosis Institute

Shwata Suresh Kumar, MPH
Health Educator II

Global Tuberculosis Institute

Daria Szwarko, DO, MPH
Assistant Professor
Brown University

Rebecca Thal, NP
Family Medicine Nurse Practitioner
Family Health Center of Worcester

Eileen Wright, MA
Program Manager
Global Health Initiative

Brown University

Ed Zuroweste, MD
TB Medical Consultant
Pennsylvania Department of Health